We outline the market outlook for digital biomarkers for vital signs in the pharma and clinical research industry – from investment trends, to leading companies, to recommendations for the players in the space.
We outline the market outlook for patient data & analytics in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for diabetes DTx in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for AI-powered drug discovery in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for the players in the space.
Pharma companies are expanding their presence in mental health tech. From digital therapeutics to drug development, we take a look at how Pfizer, Johnson & Johnson, and Sanofi are exploring opportunities in this space.
From drug discovery to regenerative medicine, this Market Map highlights the startups transforming the drug development landscape.
From real-world data to digital therapeutics, this MVP Technology Framework evaluates the tech solutions pharmaceutical companies and contract research organizations (CROs) like Pfizer and IQVIA are using to develop and deliver personalized medicine.
We outline the market outlook for remote patient monitoring in clinical research, pharma, and healthcare — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for digital twins and biosimulations in clinical research, pharma, and healthcare — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for real-world data in clinical research, pharma, and healthcare — from investment trends, to leading companies, to recommendations for players in the space.
We outline the market outlook for patient recruitment and enrollment in the clinical research, pharma, and healthcare industry — from investment trends, to leading companies, to recommendations for the players in the space.
From claims management to cost & risk analytics, this MVP Technology Framework evaluates the tech solutions that healthcare payers use to drive more accurate and timely payments processes.
From AI-powered drug discovery to quantum computing, this MVP Technology Framework evaluates the tech solutions pharmaceutical companies and contract research organizations (CROs) like Pfizer and IQVIA are using to improve drug discovery.
As pharma companies look for ways to improve chronic disease management, AstraZeneca and Eli Lilly are exploring opportunities in remote patient monitoring.
Healthcare payers are under more pressure than ever to create quick, accurate payments to healthcare providers. This market map looks at the companies helping payers create smooth, efficient payment processes to maintain a stable bottom line.
From blood pressure to vocal clarity, these startups are analyzing digital biomarkers to change how patients are monitored, diagnosed, and treated.
We mined Google’s acquisitions, investments, and partnerships to discern the company's strategic priorities in the biopharma space.
We outline the market outlook for clinical trial site management software in clinical research, pharma, and healthcare — from market size, to leading companies, to recommendations for players in the space.
Investment in global biopharma tech falls to its lowest level in recent years.
This report looks at the companies helping pharmaceutical companies and contract research organizations (CROs) discover new drugs.
We dive into the evolution of clinical trials and where the space is going next, from AI to improve recruitment to in silico trials with simulated patients.
This report looks at the vendors helping pharmaceutical companies and healthcare providers use tech like genomic profiling, digital therapeutics, and molecular diagnostics to deliver the right drug to the right patient at the right time.
We outline the market outlook for decentralized clinical trials software — from market size, to leading companies, to recommendations for players in the space.
After a record-breaking 2021, global biopharma tech investment cooled off in Q1’22.
Of the 2,700+ recently funded biopharma companies, we identified 9 of the top teams using our Management Mosaic algorithm. From clinical trials tech to anti-aging drugs, proven founders and teams are innovating in new sectors.
The funding will help Waltz Health hire new employees and invest in product development. Here are the top-line bullets you need to know.